Fri, 3 Jul 2026 · LIVE
Updated Jul 2, 2026 · 21:26
India News Updated Jul 2, 2026

NITI Aayog's 2047 Roadmap to Make Ayurveda a Global Healthcare Powerhouse

NITI Aayog has released a strategic roadmap to make Ayurveda a global healthcare and export powerhouse by 2047. The report recommends a phased approach including global recognition, enhanced research, and upgraded manufacturing standards. It notes Ayurveda exports have doubled to $2.16 billion but are limited by regulatory barriers. The roadmap aims to transform Ayurveda from a wellness system to an evidence-based, internationally accepted healthcare model.

NITI Aayog unveils roadmap to make Ayurveda a global healthcare and export powerhouse by 2047

New Delhi, July 2

NITI Aayog has released a strategic roadmap to position Ayurveda as a globally recognised healthcare system and a stronger export industry by 2047, recommending a phased strategy that includes expanding international recognition, strengthening research, upgrading manufacturing standards, and promoting medical value travel.

The report, 'Strategic Roadmap for Making Ayurveda Global', said the roadmap aligns with the vision of Viksit Bharat@2047 and seeks to transform Ayurveda into a "credible, evidence-based, and globally integrated system of healthcare."

"The roadmap outlined in this report is both ambitious and pragmatic. By adopting a phased approach extending up to 2047, it aligns well with India's broader developmental vision of Viksit Bharat@2047. The focus on building globally recognized standards, enhancing manufacturing and export competitiveness, promoting medical value travel, and leveraging India's diplomatic and cultural capital offers a clear pathway for positioning Ayurveda as a credible component of global healthcare systems," NITI Aayog Vice Chairman Ashok Kumar Lahiri said in his message in the report.

Prepared by PwC under NITI Aayog's Research Scheme, the report assesses Ayurveda's current global footprint and identifies policy measures needed to improve its availability, acceptability and global propagation. It notes that while Ayurveda's international presence is expanding, its full potential remains constrained by fragmented regulations, limited scientific validation, restricted practitioner mobility and gaps in globally aligned standards.

According to the report, Ayurveda products are now exported to around 150 countries, with exports rising from USD 1.09 billion in 2014 to USD 2.16 billion in 2023. However, it noted that most products continue to be sold overseas as dietary supplements because of regulatory barriers, limiting the export of higher-value finished Ayurvedic medicines.

To address these gaps, the roadmap recommends creating a Global Ayurveda Register, expanding mutual recognition agreements with foreign countries, introducing Ayurveda electives in international medical schools, establishing a World Federation for Ayurveda and Yoga, and strengthening evidence-based research. It also proposes upgrading India's manufacturing standards to WHO-GMP norms, creating an export-focused Ayurvedic Pharmacopoeia, setting up overseas finishing units, and publishing annual global safety and evidence reports.

The report also calls for strengthening international research by establishing more WHO collaborating centres, creating an International Ayurveda Research Alliance, promoting global clinical trials and expanding collaborations between industry and academia. It recommends developing International Ayurveda Centres of Excellence and introducing joint degree programmes with leading global medical universities to build an international practitioner base.

Highlighting the economic opportunity, the report said the globalisation of Ayurveda has the potential to generate growth across health products, wellness services and medical value travel. It added that India should move Ayurveda beyond its current perception as a wellness and complementary therapy system towards becoming an evidence-based and internationally accepted healthcare model.

"The findings and recommendations of this report are expected to support evidence-informed policymaking and contribute in strengthening India's position as a global leader in traditional medicine and promoting holistic and sustainable healthcare solutions," the report said.

— ANI

Reader Comments

Sarah B

I've used Ayurveda for my chronic sinusitis and it worked wonders after years of allopathic treatment. Happy to see India taking this seriously. But we also need more rigorous clinical trials so that the international medical community accepts it. 🍃

Priya S

Honestly, I am a bit skeptical. We have been talking about globalising Ayurveda for decades but nothing concrete happened. The real challenge is standardisation - every vaidya has different formulations. Also, will this benefit small-time practitioners or just big corporations? Need to see the implementation roadmap.

Michael C

As someone who travels to India for Ayurvedic treatments, this is long overdue. The medical value travel potential is huge. But please make the visa process simpler for wellness tourists and ensure there are proper accreditation systems for Ayurvedic hospitals and resorts. Many of us are tired of unreliable information online.

Arjun K

Finally some concrete steps! The global Ayurveda register and mutual recognition agreements are must-haves. I have seen many genuine practitioners struggle abroad because their qualifications are not recognised. Also, including Ayurveda in international medical schools curriculum is a brilliant idea to create awareness among future doctors. 👌

Rohit P

Good vision but I worry about the timeline - 2047 is too far. We need to act fast because China is aggressively promoting TCM globally. Also, the report mentions USD 2.16 billion exports but most is as dietary supplements - we need to capture the high-value pharmaceutical market. Let's hope this doesn't become another bureaucratic exercise.

<

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Reader Voices

Leave a comment

Be kind. Add to the conversation. 0/50
Thank you — your comment has been submitted.
JS blocked